|
421 |
Effects of Bifidobacterium breve 207-1 on regulating lifestyle behaviors and mental wellness in healthy adults based on the microbiome-gut-brain axis: a randomized, double-blind, placebo-controlled trial Enthalten in European journal of nutrition 13.6.2024: 1-19
|
|
|
422 |
Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: An updated systematic review and meta-analysis including the latest SURMOUNT-2 trial Enthalten in Endocrine 8.6.2024: 1-15
|
|
|
423 |
Sex differences in the acute effects of oral THC: a randomized, placebo-controlled, crossover human laboratory study Enthalten in Psychopharmacology 4.6.2024: 1-11
|
|
|
424 |
Wirksamkeit von Teprotumumab bei der chronischen endokrinen Orbitopathie Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 2: 81-82. 2 S.
|
|
|
425 |
Systemischer Lupus erythematodes: Neue Hoffnung durch Baricitinib-Therapie? Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 2: 74-76. 3 S.
|
|
|
426 |
Morbus Crohn: Vielversprechende Behandlungsoption eines neuen IL-23-Inhibitors auf dem Weg zur Zulassung Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 2: 66-69. 4 S.
|
|
|
427 |
Birmekizumab: Erweitert die Therapieoptionen besonders bei axialer Spondylarthritis Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 2: 64-65. 2 S.
|
|
|
428 |
Colitis ulcerosa: Zur Behandlung einer Anämie ist die Wirksamkeit von Spirulina-Supplement noch nicht ausreichend belegt Enthalten in Kompass Autoimmun Bd. 6, 2024, Nr. 1: 17-18. 2 S.
|
|
|
429 |
Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam Enthalten in Neuropsychopharmacology 31.5.2024: 1-11
|
|
|
430 |
Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study Enthalten in GeroScience 24.5.2024: 1-18
|
|